SHERLOCK-based one-step test provides rapid and sensitive Covid-19 detection - MIT News
external-link
BARDA Awards Revvity $9.2M, Partners With Sherlock Biosciences for COVID/Flu Home Tests
external-link
Startup Led by Dhanda ’95 Developing COVID-19 Diagnostic Tests - Wesleyan University
external-link
OraSure Technologies Acquires Sherlock Biosciences - Yahoo Finance
external-link
Sherlock is excited that the FDA recently approved an at-home test for syphilis that can provide initial results in just 15-minutes. Syphilis has been surging in recent years with the number of cases
external-link
Gene Hackers: The Young Biotech Entrepreneurs Looking To Make Billions By Editing Life Itself - Forbes
external-link
Sherlock and Tolo create CRISPR agreement - Drug Discovery News
external-link
Sherlock Biosciences Appoints Maurice Exner as Chief Scientific Officer - PR Newswire
external-link
Sherlock Bio raises $80 million to develop CRISPR-based diagnostics - Reuters.com
external-link
Sherlock Biosciences’ CEO: “It’s Better to Be Disruptive Than to Follow the Crowd”
external-link
Sherlock Biosciences opens UK biomanufacturing facility at Swavesey for host of diagnostic devices
external-link
September is Sexual Health Awareness Month. If you’re diagnosed with an #STI like #chlamydia or #gonorrhea the most important thing is getting treatment. You might be able to get treatment for your pa
external-link
Sherlock starts clinical trial for rapid OTC diagnostics for STIs - Clinical Trials Arena
external-link
CRISPR Takes on Diagnostics in the Wake of the Pandemic - CRISPR Medicine News
external-link
Sherlock starts clinical trial for rapid OTC diagnostics for STIs
external-link
Sherlock Bio uncovers additional series A money for $49M ...
external-link
Sherlock Biosciences Is Cracking At-Home and Field Diagnostics - Genetic Engineering & Biotechnology News
external-link
Sherlock tackles mystery of STI underdiagnosis with at-home test - BioWorld Online
external-link
Sherlock Biosciences Receives Grant to Advance Development of Power-free Diagnostics - PR Newswire
external-link
Dartmouth-Hitchcock starts study of new Covid-19 testing kit
external-link
Sherlock Bio raises $80 million to apply COVID-testing tech to other diseases - The Boston Globe
external-link
Gates Foundation backs 'instrument-free' molecular diagnostic tests through Sherlock, Mologic tie-up - Fierce Biotech
external-link
FDA Authorizes First-Ever Crispr Application For COVID-19 Coronavirus Test - Forbes
external-link
With Launch Of New CRISPR Company, Competition Extends To Diagnostics - Forbes
external-link
Sherlock Biosciences nabs Sense Biodetection to expand CRISPR diagnostic reach - Fierce Biotech
external-link
Sherlock Biosciences Named PM360 Trailblazer 2022 Company of the Year for Medical Device/Diagnostics
external-link
Sherlock Biosciences Starts Clinical Trial of Disposable Molecular STI Test vs. Central Lab Tests
external-link
Sherlock Biosciences unearths $80M to bring CRISPR-based tests into the home - Fierce Biotech
external-link
Sherlock tackles mystery of STI underdiagnosis with at-home test
external-link
Sherlock Biosciences Appoints Karen Davies as Chief Development Officer - PR Newswire
external-link
Sherlock, Binx to develop first CRISPR-based POC test for COVID-19 - Drug Discovery & Development
external-link
Clinical Trial Update – CRISPR-Based Diagnostics for Sars-CoV-2 and Mycobacterium - CRISPR Medicine News
external-link
Sherlock Biosciences licenses Wyss Institute’s ambient nucleic acid amplification technology from Harvard to develop highly accurate, low-cost diagnostics for point-of-need
external-link
Sherlock Biosciences Appoints Dr. Martin Madaus as Chief Operations Officer - Business Wire
external-link
A COVID-19 diagnostic that uses CRISPR gets a nod from the FDA - Chemical & Engineering News
external-link
Weekly Refresh: Sonde Health Launched API, Akeneo’s New VP, and More
external-link
Sherlock Biosciences and binx health Announce Global Partnership to Develop First CRISPR-based Point-of-care Test for COVID-19 - Business Wire
external-link
Sherlock Biosciences and Tolo Biotech Expand Collaboration to Advance Development and Adoption of CRISPR-based Diagnostics - PR Newswire
external-link
Client Corner: Meet Syntis Bio Co-founder and CEO Rahul Dhanda - Mintz
external-link
Sherlock Biosciences and Mologic Establish Strategic Partnership to Develop Instrument-free Molecular Diagnostic Tests - Business Wire
external-link
Sherlock at Apex of CRISPR-based Diagnostics after USPTO Grants Earliest Priority Patent - CRISPR Medicine News
external-link
Sherlock Biosciences and Integrated DNA Technologies (IDT) Announce Strategic Partnership for Manufacturing CRISPR SARS-CoV-2 Diagnostic and Research Products
external-link
Sherlock Biosciences CEO, Bryan Dechairo, on democratizing DNA and the power of curiosity
external-link
Flagship Pioneering names Amy Lyons senior comms director - PR Week
external-link
Sherlock, binx to develop point-of-care Covid-19 test using CRISPR technology
external-link
Sherlock Biosciences Unveils State-of-the-Art UK Biomanufacturing Facility
external-link
Fear of stigma and rejection can lead to non-disclosure of STI status
external-link
Sherlock Biosciences Acquires Sense Biodetection Advancing CRISPR-Based Diagnostics for Consumers - PR Newswire
external-link
We're committed at Sherlock Biosciences to breaking down the stigma that surrounds sexual health. Health is health. Start a conversation today.#sexualhealthmonth #talktesttreat
external-link
Sherlock Biosciences Raises $80 Million in Series B Financing to Democratize At-Home Diagnostic Testing
external-link
Sherlock Biosciences’ CEO: “It’s Better to Be Disruptive Than to Follow the Crowd” - BioSpace
external-link
OraSure Expands Into $1.5B Molecular Testing Market with Sherlock Biosciences Acquisition - StockTitan
external-link
Sherlock Biosciences licenses Wyss Institute’s ambient nucleic acid amplification technology from Harvard to develop highly accurate, low-cost diagnostics for point-of-need
external-link
Sherlock Biosciences on LinkedIn: #cervicalcancerprevention #healthcareinnovation #sherlockbiosciences…
external-link
CRISPR Comes To COVID: A Pandemic Pivot And The Push For A Simple Coronavirus Test - WBUR News
external-link
The 221b Foundation and LogicInk Announce License Agreement to Utilize Sherlock Biosciences’ CRISPR Technology to Develop Instrument-free Diagnostic for COVID-19
external-link
OraSure Technologies Acquires Sherlock Biosciences - GlobeNewswire
external-link
Sherlock Biosciences Receives Grant to Advance Development of Power-free Diagnostics
external-link
Amy Lyons joins startup Sherlock Biosciences to lead comms - PR Week
external-link
Sherlock Biosciences Appoints Karen Davies as Chief Development Officer
external-link
Sherlock Biosciences Raises $80 Million in Series B Financing to Democratize At-Home Diagnostic Testing - PR Newswire
external-link
Sherlock Biosciences Licenses US Dx Rights to CRISPR-Cas12 From Tolo Biotech
external-link
Sherlock Biosciences Acquires Sense Biodetection to Commercialize Disposable CRISPR-Based Diagnostics - Genetic Engineering & Biotechnology News
external-link
Elementary Claim: Sherlock Gains Patent Rights for Cas12 in Diagnostics - Genetic Engineering & Biotechnology News
external-link
September is Gynecological Cancer Awareness Month! The five main types are cervical, ovarian, uterine, vaginal, and vulvar cancer. Early diagnosis increases the chances of survival. #StopHPVCancer #c
external-link
Biomedical Advanced Research and Development Authority (BARDA) on LinkedIn: We are partnering with Sherlock Biosciences to develop the Sherlock...
external-link
CRISPR diagnostic maker Sherlock Biosciences says the ...
external-link
Sherlock Biosciences Receives Grant to Advance Development of Power-free Diagnostics
external-link
Sherlock's quick, CRISPR-based coronavirus test gets emergency nod
external-link
Sherlock Biosciences nabs Sense Biodetection to expand ...
external-link
The World Health Association (WHO) recently declared a global health emergency amid rising cases of mpox. While there is no immediate threat in the US, the CDC is recommending vaccinations for higher
external-link
First CRISPR test for the coronavirus approved in the United States - Nature.com
external-link
The world’s first FDA-authorized CRISPR application. Interview: Rahul Dhanda, CEO Sherlock Biosciences. - CRISPR Medicine News
external-link
Sherlock Biosciences solves C-suite mystery, tapping ...
external-link
Sherlock Biosciences licenses Wyss technology to create affordable molecular diagnostics - Harvard Office of Technology Development
external-link
Sherlock Biosciences Appoints Julie Garlikov as Chief Commercial Officer - PR Newswire
external-link
OraSure Technologies Acquires Sherlock Biosciences for Growth - TipRanks
external-link
Sherlock Biosciences and Tolo Biotech Expand Collaboration to Advance Development and Adoption of CRISPR-based Diagnostics
external-link
Sherlock Biosciences Appoints Julie Garlikov as Chief Commercial Officer
external-link
Make sure you put getting the HPV vaccine on your child’s back-to-school list! ✏️📚💉
What’s on your back-to-school list? #StopHPVCancer
#backtoschool #hpv #hpvvaccine #schoolsupplies
external-link
Sherlock Biosciences Acquires Sense Biodetection Advancing CRISPR-Based Diagnostics for Consumers
external-link
Sherlock Biosciences unearths $80M to bring CRISPR-based tests into the home
external-link
Academic institutions grant commercial license for CRISPR-based SHERLOCK diagnostic technology in developed world - MIT News
external-link
Doudna's Intellia, Zhang's Aera the latest gene editing biotechs to lay off staff - Fierce Biotech
external-link
Abudayyeh co-founds engineering biology company - Harvard School of Engineering and Applied Sciences
external-link
Sherlock Bio, Cepheid pair up to develop CRISPR diagnostics for coronavirus and more
external-link
Sherlock Biosciences Receives FDA Emergency Use Authorization for CRISPR SARS-CoV-2 Rapid Diagnostic - Business Wire
external-link
Sherlock Biosciences Acquires Sense Biodetection Advancing CRISPR-Based Diagnostics for Consumers
external-link
Sherlock Biosciences solves C-suite mystery, tapping Myriad Genetics' Dechairo as CEO
external-link
Sherlock Biosciences Starts Clinical Trial of Disposable Molecular STI Test vs. Central Lab Tests - Business Wire
external-link